81_FR_30410 81 FR 30316 - Center for Scientific Review; Notice of Closed Meeting

81 FR 30316 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 94 (May 16, 2016)

Page Range30316-30316
FR Document2016-11473

Federal Register, Volume 81 Issue 94 (Monday, May 16, 2016)
[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Page 30316]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-11473]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Biobehavior, Inflammation, and Stress.
    Date: May 19, 2016.
    Time: 3:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Andrea B. Kelly, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 
20892, (301) 455-1761, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: May 11, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11473 Filed 5-13-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                    30316                           Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices

                                                    Scientific Review, National Institutes of                 Date: June 10, 2016.                                (Catalogue of Federal Domestic Assistance
                                                    Health, 6701 Rockledge Drive, Room 4168,                  Time: 10:00 a.m. to 12:00 p.m.                      Program Nos. 93.306, Comparative Medicine;
                                                    MSC 7806, Bethesda, MD 20892, (301) 435–                  Agenda: To review and evaluate grant                93.333, Clinical Research; 93.306, 93.333,
                                                    1726, greenbergwa@csr.nih.gov.                          applications.                                         93.337, 93.393–93.396, 93.837–93.844,
                                                      Name of Committee: Center for Scientific                Place: National Institutes of Health, 6701          93.846–93.878, 93.892, 93.893, National
                                                    Review Special Emphasis Panel;                          Rockledge Drive, Bethesda, MD 20892,                  Institutes of Health, HHS)
                                                    Development and Application of PET and                  (Telephone Conference Call).
                                                                                                              Contact Person: Sharon S. Low, Scientific             Dated: May 11, 2016.
                                                    SPECT Imaging Ligands as Biomarkers for
                                                    Drug Discovery and for Pathophysiological               Review Officer, Center for Scientific Review,         Carolyn Baum,
                                                    Studies of CNS Disorders (R21).                         National Institutes of Health, 6701 Rockledge         Program Analyst, Office of Federal Advisory
                                                      Date: June 9, 2016.                                   Drive, Room 5104, MSC 5104, Bethesda, MD              Committee Policy.
                                                      Time: 1:00 p.m. to 5:00 p.m.                          20892–5104, 301–237–1487, lowss@
                                                                                                                                                                  [FR Doc. 2016–11473 Filed 5–13–16; 8:45 am]
                                                      Agenda: To review and evaluate grant                  csr.nih.gov.
                                                                                                                                                                  BILLING CODE 4140–01–P
                                                    applications.                                           (Catalogue of Federal Domestic Assistance
                                                      Place: Bahia Resort Hotel, 998 West                   Program Nos. 93.306, Comparative Medicine;
                                                    Mission Bay Drive, San Diego, CA 92109.                 93.333, Clinical Research; 93.306, 93.333,
                                                      Contact Person: Donald Scott Wright,                  93.337, 93.393–93.396, 93.837–93.844,                 DEPARTMENT OF HEALTH AND
                                                    Ph.D., Scientific Review Officer, Center for            93.846–93.878, 93.892, 93.893, National               HUMAN SERVICES
                                                    Scientific Review, National Institutes of               Institutes of Health, HHS)
                                                    Health, 6701 Rockledge Drive, Room 5108,                                                                      National Institutes of Health
                                                                                                              Dated: May 11, 2016.
                                                    MSC 7854, Bethesda, MD 20892, (301) 435–
                                                    8363, wrightds@csr.nih.gov.                             Carolyn Baum,                                         National Cancer Institute; Notice of
                                                      Name of Committee: Musculoskeletal, Oral              Program Analyst, Office of Federal Advisory           Meeting
                                                    and Skin Sciences Integrated Review Group;              Committee Policy.
                                                    Musculoskeletal Rehabilitation Sciences                 [FR Doc. 2016–11472 Filed 5–13–16; 8:45 am]
                                                                                                                                                                     Pursuant to section 10(d) of the
                                                    Study Section.                                                                                                Federal Advisory Committee Act, as
                                                                                                            BILLING CODE 4140–01–P
                                                      Date: June 10, 2016.                                                                                        amended (5 U.S.C. App. 2), notice is
                                                      Time: 8:00 a.m. to 6:00 p.m.                                                                                hereby given of the joint meeting of the
                                                      Agenda: To review and evaluate grant                  DEPARTMENT OF HEALTH AND                              National Cancer Advisory Board
                                                    applications.                                                                                                 (NCAB) and NCI Board of Scientific
                                                      Place: Sheraton BWI (Baltimore), 1100 Old
                                                                                                            HUMAN SERVICES
                                                                                                                                                                  Advisors (BSA).
                                                    Elkridge Landing Road, Baltimore, MD                                                                             The meeting will be open to the
                                                    21090.
                                                                                                            National Institutes of Health
                                                                                                                                                                  public as indicated below, with
                                                      Contact Person: Maria Nurminskaya, Ph.D.,
                                                    Scientific Review Officer, Center for
                                                                                                            Center for Scientific Review; Notice of               attendance limited to space available.
                                                    Scientific Review, National Institutes of               Closed Meeting                                        Individuals who plan to attend and
                                                    Health, Bethesda, MD 20892, (301) 435–1222,                                                                   need special assistance, such as sign
                                                                                                              Pursuant to section 10(d) of the
                                                    nurminskayam@csr.nih.gov.                                                                                     language interpretation or other
                                                                                                            Federal Advisory Committee Act, as
                                                      Name of Committee: Biological Chemistry                                                                     reasonable accommodations, should
                                                                                                            amended (5 U.S.C. App.), notice is
                                                    and Macromolecular Biophysics Integrated                                                                      notify the Contact Person listed below
                                                                                                            hereby given of the following meeting.
                                                    Review Group; Macromolecular Structure
                                                                                                              The meeting will be closed to the                   in advance of the meeting. The open
                                                    and Function D Study Section.                                                                                 session will be videocast and can be
                                                      Date: June 10, 2016.                                  public in accordance with the
                                                                                                            provisions set forth in sections                      accessed from the NIH Videocasting and
                                                      Time: 8:00 a.m. to 6:00 p.m.                                                                                Podcasting Web site (http://
                                                      Agenda: To review and evaluate grant                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                            as amended. The grant applications and                videocast.nih.gov).
                                                    applications.
                                                      Place: Bethesda North Marriott Hotel &                the discussions could disclose                           A portion of the National Cancer
                                                    Conference Center, 5701 Marinelli Road,                 confidential trade secrets or commercial              Advisory Board meeting will be closed
                                                    Bethesda, MD 20852.                                     property such as patentable material,                 to the public in accordance with the
                                                      Contact Person: James W. Mack, Ph.D.,                 and personal information concerning                   provisions set forth in sections
                                                    Scientific Review Officer, Center for
                                                                                                            individuals associated with the grant                 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
                                                    Scientific Review, National Institutes of                                                                     as amended. The grant applications and
                                                    Health, 6701 Rockledge Drive, Room 4154,                applications, the disclosure of which
                                                                                                            would constitute a clearly unwarranted                the discussions could disclose
                                                    MSC 7806, Bethesda, MD 20892, (301) 435–                                                                      confidential trade secrets or commercial
                                                    2037, mackj2@csr.nih.gov.                               invasion of personal privacy.
                                                                                                                                                                  property such as patentable material,
                                                      Name of Committee: Center for Scientific                Name of Committee: Center for Scientific            and personal information concerning
                                                    Review Special Emphasis Panel; Enabling                 Review Special Emphasis Panel; Biobehavior,           individuals associated with the grant
                                                    Imaging Technologies.                                   Inflammation, and Stress.
                                                      Date: June 10, 2016.                                    Date: May 19, 2016.
                                                                                                                                                                  applications, the disclosure of which
                                                      Time: 8:00 a.m. to 6:00 p.m.                            Time: 3:30 p.m. to 4:30 p.m.                        would constitute a clearly unwarranted
                                                      Agenda: To review and evaluate grant                    Agenda: To review and evaluate grant                invasion of personal privacy.
                                                    applications.                                           applications.                                           Name of Committee: National Cancer
                                                      Place: Embassy Suites at the Chevy Chase                Place: National Institutes of Health, 6701          Advisory Board; Ad Hoc Subcommittee on
                                                    Pavilion, 4300 Military Road NW.,                       Rockledge Drive, Bethesda, MD 20892                   Global Cancer Research.
                                                    Washington, DC 20015.                                   (Telephone Conference Call).                            Open: June 20, 2016, 4:30 p.m. to 6:00 p.m.
                                                      Contact Person: Maria DeBernardi, Ph.D.,                Contact Person: Andrea B. Kelly, Ph.D.,               Agenda: Discussion on Global Cancer
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    Scientific Review Officer, Center for                   Scientific Review Officer, Center for                 Research.
                                                    Scientific Review, National Institutes of               Scientific Review, National Institutes of               Place: Hyatt Regency Bethesda, One
                                                    Health, 6701 Rockledge Drive, Room 6158,                Health, 6701 Rockledge Drive, Room 3182,              Bethesda Metro Center, 7400 Wisconsin
                                                    MSC 7892, Bethesda, MD 20892, 301–435–                  MSC 7770, Bethesda, MD 20892, (301) 455–              Avenue, Bethesda, Maryland 20814.
                                                    1355, debernardima@csr.nih.gov.                         1761, kellya2@csr.nih.gov.                              Contact Person: Dr. Edward Trimble,
                                                      Name of Committee: Center for Scientific                This notice is being published less than 15         Executive Secretary, NCAB Ad Hoc
                                                    Review Special Emphasis Panel; PAR 13–                  days prior to the meeting due to the timing           Subcommittee on Global Cancer Research,
                                                    345: Development of Pediatric Formulations              limitations imposed by the review and                 National Cancer Institute—Shady Grove,
                                                    and Drug Delivery Systems.                              funding cycle.                                        National Institutes of Health, 9609 Medical



                                               VerDate Sep<11>2014   18:48 May 13, 2016   Jkt 238001   PO 00000   Frm 00080   Fmt 4703   Sfmt 4703   E:\FR\FM\16MYN1.SGM   16MYN1



Document Created: 2016-05-14 01:17:16
Document Modified: 2016-05-14 01:17:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 19, 2016.
FR Citation81 FR 30316 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR